Skip to main content
. 2020 Jan 17:135–150. doi: 10.1016/B978-0-12-817778-5.00007-5

Table 7.2.

List of antigens delivered by nanocarriers for the treatment of different diseases in vaccine research.

Antigen Nanocarrier used Disease
Against Bacterial Infection
Antigenic protein Poly(D,L-lactic-co-glycolic acid) nanospheres Anthrax
DNA encoding T cell epitopes of Esat-6 and FL Chitosan nanoparticle Tuberculosis
Mycobacterium lipids Chitosan nanoparticle Tuberculosis
Polysaccharides Liposomes Pneumonia
Bacterial toxic and parasitic protein Liposomes Cholera and malaria
Fusion protein Liposomes Helicobacter pylori infection
Antigenic protein Nanoemulsion Cystic fibrosis
Antigenic protein Nanoemulsion Anthrax
Mycobacterium fusion protein Liposome Tuberculosis
Against Viral Infection
Antigenic protein Chitosan nanoparticles Hepatitis B
Viral protein Gold nanoparticles Foot and mouth disease
Membrane protein Gold nanoparticles Influenza
Viral plasmid DNA Gold nanoparticles HIV
Tetanus toxoid Poly(D,L-lactic-co-glycolic acid) nanospheres Tetanus
Hepatitis B surface antigen Poly(D,L-lactic-co-glycolic acid) nanospheres Hepatitis B
Hepatitis B surface antigen Alginate-coated chitosan nanoparticle Hepatitis B
Live virus vaccine Chitosan nanoparticles Newcastle disease
Capsid protein VLPs Norwalk virus infection
Capsid protein VLPs Norwalk virus infection
Influenza virus structural protein VLPs Influenza
Nucleocapsid protein VLPs Hepatitis
Fusion protein VLPs Human papilloma virus
Multiple proteins VLPs Rotavirus
Virus proteins VLPs Blue tongue virus
Enveloped single protein VLPs HIV
Viral protein Polypeptide nanoparticles Corona virus for severe acute respiratory syndrome (SARS)
Against Parasitic Infection
Merozoite surface protein Iron oxide nanoparticles Malaria
Epitope of Plasmodium berghei circumsporozoite protein. Polypeptide nanoparticles Rodent malarial parasitic infection
Surface protein from Eimeria falciformis sporozoites ISCOMs Diarrhea

From Pati R, Shevtsov M, Sonawane A. Nanoparticle vaccines against infectious diseases. Front Immunol 2018;9. adapted with permission.